GlassScriptPhysician profile
Michele Hodges
NPI 1962061101
$1,245.26
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.37 · 2023: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $280.65 | 2023 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $225.18 | 2023 | |
| Abbvie INC. | $139.38 | 2023 | |
| Amgen INC. | $138.81 | 2023 | Repatha, Prolia, Evenity |
| Lilly USA, LLC | $114.23 | 2023 | Mounjaro, Trulicity, Jardiance |
| Otsuka America Pharmaceutical, INC. | $79.69 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $33.70 | 2023 | Xarelto |
| Lifescan, INC. | $30.67 | 2023 | |
| Glaxosmithkline, LLC. | $27.09 | 2023 | Trelegy Ellipta |
| Xeris Pharmaceuticals, INC. | $24.74 | 2023 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.67 | 2023 | Trulance, Xifaxan |
| Dynavax Technologies Corporation | $21.22 | 2023 | Heplisav-B |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.48 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $19.42 | 2023 | Fasenra |
| Idorsia Pharmaceuticals US INC | $19.05 | 2023 | Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.37 | 2022 | |
| Edwards Lifesciences Corporation | $15.37 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kowa Pharmaceuticals America, INC. | $14.54 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.